246 related articles for article (PubMed ID: 36448910)
1. An oral phenylacrylic acid derivative suppressed hepatic stellate cell activation and ameliorated liver fibrosis by blocking TGF-β1 signalling.
Xue T; Yue L; Zhu G; Tan Z; Liu H; Gan C; Fan C; Su X; Xie Y; Ye T
Liver Int; 2023 Mar; 43(3):718-732. PubMed ID: 36448910
[TBL] [Abstract][Full Text] [Related]
2. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
3. Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway.
Mu M; Zuo S; Wu RM; Deng KS; Lu S; Zhu JJ; Zou GL; Yang J; Cheng ML; Zhao XK
Drug Des Devel Ther; 2018; 12():4107-4115. PubMed ID: 30584275
[TBL] [Abstract][Full Text] [Related]
4. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
5. Methyl ferulic acid attenuates liver fibrosis and hepatic stellate cell activation through the TGF-β1/Smad and NOX4/ROS pathways.
Cheng Q; Li C; Yang CF; Zhong YJ; Wu D; Shi L; Chen L; Li YW; Li L
Chem Biol Interact; 2019 Feb; 299():131-139. PubMed ID: 30543783
[TBL] [Abstract][Full Text] [Related]
6. BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling.
Chung YH; Huang YH; Chu TH; Chen CL; Lin PR; Huang SC; Wu DC; Huang CC; Hu TH; Kao YH; Tai MH
Lab Invest; 2018 Aug; 98(8):999-1013. PubMed ID: 29789683
[TBL] [Abstract][Full Text] [Related]
7. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
8. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
9. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
10. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
11. RNA sequencing of LX-2 cells treated with TGF-β1 identifies genes associated with hepatic stellate cell activation.
Carson JP; Robinson MW; Ramm GA; Gobert GN
Mol Biol Rep; 2021 Dec; 48(12):7677-7688. PubMed ID: 34648138
[TBL] [Abstract][Full Text] [Related]
12. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
13. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
Zhou LH; Chen X
Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
[TBL] [Abstract][Full Text] [Related]
14. The common dietary flavonoid myricetin attenuates liver fibrosis in carbon tetrachloride treated mice.
Geng Y; Sun Q; Li W; Lu ZM; Xu HY; Shi JS; Xu ZH
Mol Nutr Food Res; 2017 Apr; 61(4):. PubMed ID: 27983763
[TBL] [Abstract][Full Text] [Related]
15. Discovery and evaluation of phenacrylanilide derivatives as novel potential anti-liver fibrosis agents.
Yue L; Xue T; Su X; Liu Z; Liu H; Tan Z; Gan C; Xie Y; Ye T
Eur J Med Chem; 2022 Nov; 242():114685. PubMed ID: 36037790
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition.
Zheng J; Wang W; Yu F; Dong P; Chen B; Zhou MT
Cell Physiol Biochem; 2018; 46(1):82-92. PubMed ID: 29587268
[TBL] [Abstract][Full Text] [Related]
17. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
[TBL] [Abstract][Full Text] [Related]
18. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
[TBL] [Abstract][Full Text] [Related]
19. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
Perumal N; Perumal M; Halagowder D; Sivasithamparam N
Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
[TBL] [Abstract][Full Text] [Related]
20. [Hydroxynitone suppresses hepatic stellate cell activation by inhibiting TGF-β1 phosphorylation to alleviate CCl
Zhao Z; Dong H; Li B; Shen B; Guo Y; Gu T; Qu Y; Cai X; Lu L
Nan Fang Yi Ke Da Xue Xue Bao; 2022 Oct; 42(10):1511-1516. PubMed ID: 36329585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
